Taxol: High activity in human gastric carcinoma cell lines
U. Vanhoefer, S. Seeber, N. Schlcucher, M. E. Scheulen, H. Wilke(Palmetto Hematology Oncology), Carolyn Schmiedel, A. Harstrick(Merck KGaA, Darmstadt (Germany)), Michael Ståhl(Berlin Institute of Health at Charité - Universitätsmedizin Berlin)
Cited by 0
Related Papers
Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck
|Journal of Clinical Oncology|2005|491
Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis
|Genes & Development|2009|351
Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor Receptor
|Journal of Clinical Oncology|2003|259
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2020|202
Sch9 regulates ribosome biogenesis via Stb3, Dot6 and Tod6 and the histone deacetylase complex RPD3L
|The EMBO Journal|2011|179